Neonatal group B streptococcal cellulitis-adenitis

Pediatr Dermatol. 1993 Mar;10(1):58-60. doi: 10.1111/j.1525-1470.1993.tb00016.x.

Abstract

A 38-day-old prematurely born infant developed rapidly progressive facial cellulitis in association with ipsilateral submandibular lymphadenopathy and pulmonary consolidation. Group B streptococci (GBS) were isolated from blood, endotracheal, and lesion cultures. Prompt recognition of GBS cellulitis-adenitis and institution of parenteral, synergistic antibiotic therapy are important.

Publication types

  • Case Reports

MeSH terms

  • Ampicillin / therapeutic use
  • Cellulitis / drug therapy
  • Cellulitis / microbiology*
  • Drug Therapy, Combination / therapeutic use
  • Facial Dermatoses / microbiology
  • Female
  • Follow-Up Studies
  • Gentamicins / therapeutic use
  • Humans
  • Infant, Newborn
  • Infant, Premature, Diseases / drug therapy
  • Infant, Premature, Diseases / microbiology*
  • Lymphadenitis / drug therapy
  • Lymphadenitis / microbiology*
  • Streptococcal Infections* / drug therapy
  • Streptococcus agalactiae*

Substances

  • Gentamicins
  • Ampicillin